Cardinal Capital Management Inc (Canada)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $35.4M | Sell |
190,773
-6,840
| -3% | -$1.27M | 1.11% | 27 |
|
2025
Q1 | $41.4M | Buy |
197,613
+289
| +0.1% | +$60.6K | 1.41% | 22 |
|
2024
Q4 | $35.1M | Sell |
197,324
-103
| -0.1% | -$18.3K | 1.19% | 26 |
|
2024
Q3 | $39M | Buy |
197,427
+588
| +0.3% | +$116K | 1.61% | 15 |
|
2024
Q2 | $33.8M | Buy |
196,839
+348
| +0.2% | +$59.7K | 1.3% | 19 |
|
2024
Q1 | $35.8M | Sell |
196,491
-3,561
| -2% | -$648K | 1.59% | 18 |
|
2023
Q4 | $31M | Buy |
200,052
+525
| +0.3% | +$81.4K | 1.47% | 19 |
|
2023
Q3 | $29.7M | Buy |
199,527
+1,447
| +0.7% | +$216K | 1.55% | 19 |
|
2023
Q2 | $26.7M | Buy |
198,080
+420
| +0.2% | +$56.6K | 1.34% | 25 |
|
2023
Q1 | $31.5M | Buy |
197,660
+24,546
| +14% | +$3.91M | 1.71% | 16 |
|
2022
Q4 | $28M | Buy |
173,114
+5,282
| +3% | +$854K | 1.58% | 18 |
|
2022
Q3 | $22.5M | Buy |
167,832
+3,960
| +2% | +$531K | 1.37% | 17 |
|
2022
Q2 | $25.1M | Buy |
163,872
+11,777
| +8% | +$1.8M | 1.39% | 16 |
|
2022
Q1 | $24.7M | Buy |
152,095
+137,885
| +970% | +$22.4M | 1.2% | 22 |
|
2021
Q4 | $1.92M | Buy |
14,210
+150
| +1% | +$20.3K | 0.09% | 45 |
|
2021
Q3 | $1.52M | Buy |
14,060
+2,233
| +19% | +$241K | 0.08% | 43 |
|
2021
Q2 | $1.33M | Buy |
11,827
+202
| +2% | +$22.8K | 0.07% | 44 |
|
2021
Q1 | $1.26M | Buy |
11,625
+1,425
| +14% | +$154K | 0.07% | 44 |
|
2020
Q4 | $1.09M | Buy |
10,200
+445
| +5% | +$47.7K | 0.07% | 47 |
|
2020
Q3 | $854K | Buy |
9,755
+465
| +5% | +$40.7K | 0.06% | 48 |
|
2020
Q2 | $912K | Buy |
9,290
+2,105
| +29% | +$207K | 0.08% | 43 |
|
2020
Q1 | $547K | Buy |
7,185
+6,530
| +997% | +$497K | 0.05% | 48 |
|
2019
Q4 | $58K | Buy |
+655
| New | +$58K | ﹤0.01% | 55 |
|